特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外式膜型人工肺(ECMO)の世界市場:2020年~2024年

Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 920954
出版日 ページ情報 英文 155 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.51円で換算しております。
体外式膜型人工肺(ECMO)の世界市場:2020年~2024年 Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2020-2024
出版日: 2019年11月21日 ページ情報: 英文 155 Pages
概要

世界の体外式膜型人工肺、通称ECMO(エクモ) 市場は、呼吸器疾患や心不全の発生率の増加、新製品発売の増加、移植手技の増加などが成長促進要因となり、予測期間中に約5%のCAGRで拡大する見込みです。ただし、心臓および呼吸器の治療に関連する費用の高さ、ECMO処置に伴う合併症、および頻繁な製品リコールなどの要因が、予測期間中の体外式膜型人工肺市場の成長を妨げる可能性があります。

当レポートでは、世界の体外式膜型式人工肺(ECMO)市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場の特徴
  • バリューチェーン分析
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場規模(2019年)
  • 市場規模および予測(2019年~2024年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 顧客情勢

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第8章 市場セグメンテーション:モダリティ別

  • 市場セグメンテーション:モダリティ別
  • モダリティ別比較:市場規模および予測(2019年~2024年)
  • 静静脈および動静脈
  • 静動脈
  • 市場機会:モダリティ別

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 技術の進歩
  • M&A
  • 市場のビジネス戦略

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Alung Technologies Inc.
  • Eurosets Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • ニプロ
  • OriGen Biomedical Inc.
  • テルモ

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Customer landscape
  • Exhibit 19: Market share by geography 2019-2024 (%)
  • Exhibit 20: Geographic comparison
  • Exhibit 21: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 22: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 23: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 24: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 25: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 26: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 27: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 28: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 29: Key leading countries
  • Exhibit 30: Market opportunity
  • Exhibit 31: Modality - Market share 2019-2024 (%)
  • Exhibit 32: Comparison by modality
  • Exhibit 33: Veno-venous and arterio-venous - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 34: Veno-venous and arterio-venous - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: Veno-arterial - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: Veno-arterial - Year-over-year growth 2020-2024 (%)
  • Exhibit 37: Market opportunity by modality
  • Exhibit 38: Product launch details and market impact analysis
  • Exhibit 39: Product recalls
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Business strategies and their market impact analysis
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Alung Technologies Inc. - Vendor overview
  • Exhibit 48: Alung Technologies Inc. - Product segments
  • Exhibit 49: Alung Technologies Inc. - Key offerings
  • Exhibit 50: Alung Technologies Inc. - Key customers
  • Exhibit 51: Eurosets Srl - Vendor overview
  • Exhibit 52: Eurosets Srl - Product segments
  • Exhibit 53: Eurosets Srl - Organizational developments
  • Exhibit 54: Eurosets Srl - Key offerings
  • Exhibit 55: Eurosets Srl - Key customers
  • Exhibit 56: Fresenius Medical Care AG & Co. KGaA - Vendor overview
  • Exhibit 57: Fresenius Medical Care AG & Co. KGaA - Business segments
  • Exhibit 58: Fresenius Medical Care AG & Co. KGaA - Organizational developments
  • Exhibit 59: Fresenius Medical Care AG & Co. KGaA - Geographic focus
  • Exhibit 60: Fresenius Medical Care AG & Co. KGaA - Segment focus
  • Exhibit 61: Fresenius Medical Care AG & Co. KGaA - Key offerings
  • Exhibit 62: Fresenius Medical Care AG & Co. KGaA - Key customers
  • Exhibit 63: Getinge AB - Vendor overview
  • Exhibit 64: Getinge AB - Business segments
  • Exhibit 65: Getinge AB - Organizational developments
  • Exhibit 66: Getinge AB - Geographic focus
  • Exhibit 67: Getinge AB - Segment focus
  • Exhibit 68: Getinge AB - Key offerings
  • Exhibit 69: Getinge AB - Key customers
  • Exhibit 70: LivaNova Plc - Vendor overview
  • Exhibit 71: LivaNova Plc - Business segments
  • Exhibit 72: LivaNova Plc - Organizational developments
  • Exhibit 73: LivaNova Plc - Geographic focus
  • Exhibit 74: LivaNova Plc - Segment focus
  • Exhibit 75: LivaNova Plc - Key offerings
  • Exhibit 76: LivaNova Plc - Key customers
  • Exhibit 77: Medtronic Plc - Vendor overview
  • Exhibit 78: Medtronic Plc - Business segments
  • Exhibit 79: Medtronic Plc - Organizational developments
  • Exhibit 80: Medtronic Plc - Geographic focus
  • Exhibit 81: Medtronic Plc - Segment focus
  • Exhibit 82: Medtronic Plc - Key offerings
  • Exhibit 83: Medtronic Plc - Key customers
  • Exhibit 84: MicroPort Scientific Corp. - Vendor overview
  • Exhibit 85: MicroPort Scientific Corp. - Business segments
  • Exhibit 86: MicroPort Scientific Corp. - Organizational developments
  • Exhibit 87: MicroPort Scientific Corp. - Geographic focus
  • Exhibit 88: MicroPort Scientific Corp. - Segment focus
  • Exhibit 89: MicroPort Scientific Corp. - Key offerings
  • Exhibit 90: MicroPort Scientific Corp. - Key customers
  • Exhibit 91: NIPRO Corp. - Vendor overview
  • Exhibit 92: NIPRO Corp. - Product segments
  • Exhibit 93: NIPRO Corp. - Geographic focus
  • Exhibit 94: NIPRO Corp. - Segment focus
  • Exhibit 95: NIPRO Corp. - Key offerings
  • Exhibit 96: NIPRO Corp. - Key customers
  • Exhibit 97: OriGen Biomedical Inc. - Vendor overview
  • Exhibit 98: OriGen Biomedical Inc. - Product segments
  • Exhibit 99: OriGen Biomedical Inc. - Organizational developments
  • Exhibit 100: OriGen Biomedical Inc. - Key offerings
  • Exhibit 101: OriGen Biomedical Inc. - Key customers
  • Exhibit 102: Terumo Corp. - Vendor overview
  • Exhibit 103: Terumo Corp. - Business segments
  • Exhibit 104: Terumo Corp. - Organizational developments
  • Exhibit 105: Terumo Corp. - Geographic focus
  • Exhibit 106: Terumo Corp. - Segment focus
  • Exhibit 107: Terumo Corp. - Key offerings
  • Exhibit 108: Terumo Corp. - Key customers
  • Exhibit 109: Validation techniques employed for market sizing
  • Exhibit 110: Definition of market positioning of vendors
目次
Product Code: IRTNTR40185

About this market

Technavio's extracorporeal membrane oxygenation machines market analysis considers sales from veno-venous and arterio-venous; and veno-arterial modalities. Our study also finds the sales of extracorporeal membrane oxygenation machines in Asia, Europe, North America, and ROW. In 2019, the veno-venous and arterio-venous segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing cases of lung transplants will play a significant role in the veno-venous and arterio-venous segment to maintain its market position. Also, our global extracorporeal membrane oxygenation machines market report looks at factors such as increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of transplant procedures. However, high costs associated with cardiac and respiratory procedures, complications related to ECMO procedures, and frequent product recalls may hamper the growth of the extracorporeal membrane oxygenation machines industry over the forecast period.

Overview

Increasing prevalence of respiratory and heart failure

Respiratory diseases such as COPD, ARDS, and pulmonary embolism affect a large number of people across the world every year. The rising prevalence of these diseases can be attributed to factors such as respiratory infections, smoking, and air pollution. Similarly, the prevalence of CVDs and other heart diseases such as ischemic heart disease, coronary heart disease, and myocardial infarctions has significantly increased over recent years. These factors have increased the number of emergency department visits, which has necessitated the need for immediate treatment. Extracorporeal membrane oxygenation machines are majorly used for reducing the chances of cardiac failure in people with CVDs. They are also used by healthcare professionals to help patients at the risk of sudden respiratory failure. Therefore, the increasing incidences of respiratory and heart failures will lead to the expansion of the global extracorporeal membrane oxygenation machines market at a CAGR of almost 5% during the forecast period.

Technological advances

The growing number of technological innovations has enabled a paradigm shift in the cost as well as the manageability of medical equipment. The launch of wearable devices has made patient monitoring much simpler and more cost-effective and has contributed to better patient adherence to health monitoring. Extracorporeal membrane oxygenation machines are majorly used in hospitals, clinics, and ASCs as a life-support device. They are majorly used by healthcare professionals during certain medical emergencies and surgical procedures. Technologically advanced and innovative devices are majorly used by clinicians for patients suffering from certain chronic conditions where support for the heart and lung is required. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global extracorporeal membrane oxygenation machines market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global extracorporeal membrane oxygenation machines market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines manufacturers, that include ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG & Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., NIPRO Corp., OriGen Biomedical Inc., and Terumo Corp.

Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market sizing 2019
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 08: MARKET SEGMENTATION BY MODALITY

  • Market segmentation by modality
  • Comparison by modality
  • Veno-venous and arterio-venous - Market size and forecast 2019-2024
  • Veno-arterial - Market size and forecast 2019-2024
  • Market opportunity by modality

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advances
  • Mergers and acquisitions
  • Business strategies in the market

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Alung Technologies Inc.
  • Eurosets Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • NIPRO Corp.
  • OriGen Biomedical Inc.
  • Terumo Corp.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO